Psyomics

Psyomics spun out from the University of Cambridge and is led by ex-NHS clinicians. Psyomics continues to complete research in collaboration with Cambridge University labs and currently covers 8m lives through the NHS. In 2025, Psyomics was selected (as only one of two mental health suppliers) to be part of the NHS Innovation Accelerator.

Psyomics is clinically led and specialises in digital mental health, specifically designing products that support the NHS. With a suite covering adults, children and neurodevelopmental services, Psyomics aims to provide a ubiquitous front door across all entry points to mental health services, and to all system providers.

Focused on inefficiencies between referral and getting to definitive treatment, their tools support clinicians to reduce their admin and support their clinical decision making with digital data capture directly from the patient or service user. Automations and integrations into established electronic records minimise admin resources and they are able to consistently show routes to in-year ‘return on investment’ through the reduction of non-face to face clinical activity.

The Psyomics platform brings the patient's voice into the journey from the very start, helping to inform pathway decisions which can otherwise lead to multiple waits on various waiting lists. It also provides a consistent approach to entry points across your system which can help with standardised MDT and assessment practices.